The investigators will evaluate the accuracy of performing cytological imprints of targeted
biopsies when diagnosing prostate cancer.
It is useful to know whether the biopsy is cancer or not, in order to know when to stop
sampling and when to continue.
The strategy is used in other types of cancer, e.g lung, breast etc